Synthesis and intracellular localization of vaccinia virus deoxyribonucleic acid-dependent ribonucleic acid polymerase.
The time course of vaccinia deoxyribonucleic acid (DNA)-dependent ribonucleic acid (RNA) polymerase synthesis and its intracellular localization were studied with virus-infected HeLa cells. Viral RNA polymerase activity could be meassured shortly after viral infection in the cytoplasmic fraction of infected cells in vitro. However, unless the cells were broken in the presence of the nonionic detergent Triton-X-100, no significant synthesis of new RNA polymerase was detected during the viral growth cycle. When cells were broken in the presence of this detergent, extensive increases in viral RNA polymerase activity were observed late in the infection cycle. The onset of new RNA polymerase synthesis was dependent on prior viral DNA replication. Fluorodeoxyuridine (5 x 10(-5)m) prevented the onset of viral polymerase synthesis. Streptovitacin A, a specific and complete inhibitor of protein synthesis in HeLa cells, prevented the synthesis of RNA polymerase. Thus, the synthesis of RNA polymerase is a "late" function of the virus. The newly synthesized RNA polymerase activity was primarily bound to particles which sedimented during high-speed centrifugation. These particles have been characterized by sucrose gradient centrifugation. A major class of active RNA polymerase particles were considerably "lighter" than whole virus in sucrose gradients. These particles were entirely resistant to the action of added pancreatic deoxyribonuclease, and they were not stimulated by added calf thymus primer DNA. It is concluded that these particles are not active in RNA synthesis in vivo, and that activation occurs as a result of detergent treatment in vitro.
D000818:Animals; D002417:Cattle; D002499:Centrifugation, Density Gradient; D003593:Cytoplasm / Q000032:analysis; D004247:DNA / Q000494:pharmacology; D004261:DNA Replication; D004279:DNA, Viral; D003851:Deoxyribonucleases / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D006367:HeLa Cells; D012316:RNA Nucleotidyltransferases / Q000032:analysis / Q000096:biosynthesis*; D011874:Radiometry; D013395:Sucrose; D013501:Surface-Active Agents / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014616:Vaccinia virus / Q000254:growth & development*
D004279:DNA, Viral; D013501:Surface-Active Agents; D005467:Floxuridine; D014316:Tritium; D013395:Sucrose; D004247:DNA; D012316:RNA Nucleotidyltransferases; D003851:Deoxyribonucleases; D013936:Thymidine; D014529:Uridine